Adaptyx's biowearable platform redefines continuous health monitoring, moving beyond glucose to capture a much wider range of human biochemistry, including small molecules, electrolytes, hormones, drugs, and proteins, making visible what has long been hidden between lab visits. By pairing continuous molecular sensing with AI-powered analytics, the platform transforms these data streams into actionable insights, enabling earlier detection of health trends and timely interventions before issues escalate.
"Healthcare suffers from a data deficit," said Vijit Sabnis, Ph.D., CEO & Co‑Founder, Adaptyx. "Lab tests are only snapshots of health and don't capture the body's changing physiology, leaving blind spots that prevent addressing many of today's health challenges. Adaptyx gives patients and clinicians a continuous view of what's happening inside the body, transforming previously unseen molecular signals into empowering insights. Our mission is to expand continuous monitoring beyond glucose to include the many molecules that drive human health, creating a rich data pipeline that guides patients and clinicians to make the best decisions at the right time. We're starting with life-saving clinical applications and will ultimately bring this capability to everyone."
At the core of Adaptyx's proprietary technology are programmable molecular ...
